Ribosomal protein metallopanstimulin-1 impairs multiple myeloma CAG cells growth and inhibits fibroblast growth factor receptor 3

Clinical Lymphoma, Myeloma and Leukemia

Volumn 11, Issue 6, 2011, Pages 490-497

  Dai, Yuemeng ^a   Pierson, Spencer ^a   Dudney, Cross ^a   Zeng, Yuxin ^b   MacLeod, Veronica ^b   Shaughnessy, John D ^b   Stack Jr , Brendan C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Fibroblast growth factor receptor (FGFR3); Metallopanstimulin 1; Multiple myeloma; RPS27

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; METALLOPANSTIMULIN 1; MITOGEN ACTIVATED PROTEIN KINASE; PAXILLIN; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT FIBROBLAST GROWTH FACTOR RECEPTOR 3; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 84860632920     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2011.06.015     Document Type: Article

References (20)

1. Wilson DM, Deutsch WA, Kelley MR. Drosophila ribosomal protein S3 contains an activity that cleaves DNA at apurinic/apyrimidinic sites. J Biol Chem 1994; 269:25359-64. (Pubitemid 24336217)
2. Sandigursky M, Yacoub A, Kelley MR, et al. The Drosophila ribosomal protein S3 contains a DNA deoxyribophosphodiesterase (dRpase) activity. J Biol Chem 1997; 272:17480-4. (Pubitemid 27311180)
3. Jang CY, Lee JY, Kim J. RpS3, a DNA repair endonuclease and ribosomal protein is involved in apoptosis FEBS Lett 2004; 560:81-5. (Pubitemid 38264297)
4. Khanna N, Sen S, Sharma H, et al. S29 ribosomal protein induces apoptosis in H520 cells and sensitizes them to chemotherapy. Biochem Biophys Res Commun 2003; 304:26-35. (Pubitemid 36434189)
5. He H, Sun Y. Ribosomal protein S27L is a direct p53 target that regulates apoptosis Oncogene 2007; 26:2707-16. (Pubitemid 46663829)
6. Shi Y, Zhai H, Wang X, et al. Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis. Exp Cell Res 2004; 296:337-46. (Pubitemid 38624654)
7. Hamaguchi I, Ooka A, Brun A, et al. Gene transfer improves erythroid development in ribosomal protein S19-deficient Diamond-Blackfan anemia. Blood 2002; 100:2724-31.
8. Naora H, Takai I, Adachi M, et al. Altered cellular responses by varying expression of a ribosomal protein gene: sequential coordination of enhancement and suppression of ribosomal protein S3a gene expression induces apoptosis. J Cell Biol 1998; 141:741-53. (Pubitemid 28217918)
9. Dai YM, Pierson S, Dudney C, et al. Extra-ribosomal function of metallopanstimulin- 1: reducing paxillin in head and neck squamous cell carcinoma and inhibiting tumor growth. Int J Cancer 2010; 126:611-9.
10. Fernandez-Pol JA, Klos DJ, Hamilton PD. A growth factor-inducible gene encodes a novel nuclear protein with zinc finger structure. J Biol Chem 1993; 268:21198-204. (Pubitemid 23292307)
11. Ebert BL, Pretz J, Bosco J, et al. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 2008; 451:335-9.
12. Borset M, Hjertner O, Yaccoby S, et al. Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins. Blood 2000; 96:2528-36.
13. Zhan F, Hardin J, Kordsmeier B, et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 2002; 99:1745-57. (Pubitemid 34533050)
14. Olave IA, Reck-Peterson SK, Crabtree GR. Nuclear actin and actin related proteins in chromatin remodeling. Ann Rev Biochem 2002; 71:755-81. (Pubitemid 34800234)
15. Chesi M, Brents LA, Ely SA, et al. Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma. Blood 2001; 97:729-36. (Pubitemid 32113407)
16. Li Z, Zhu YX, Plowright EE, et al. The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells. Blood 2001; 97:2413-9. (Pubitemid 32291488)
17. Grand EK, Chase AJ, Heath C, et al. Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074. Leukemia 2004; 18:962-6. (Pubitemid 38714621)
18. Qing J, Du X, Chen Y, et al. Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice. J Clin Invest 2009; 119: 1216-29.
19. Zhu L, Somlo G, Zhou B, et al. Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma. Mol Cancer Ther 2005; 4:787-98. (Pubitemid 40767123)
20. Trudel S, Ely S, Farooqi Y, et al. Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma. Blood 2004; 103: 3521-8. (Pubitemid 38525687)